Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
March 21, 2022 at 04:49 am EDT
Share
Kyung Dong Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was KRW 177,610.83 million compared to KRW 173,827.66 million a year ago. Net income was KRW 12,671.99 million compared to KRW 12,459.2 million a year ago.
Basic earnings per share from continuing operations was KRW 460 compared to KRW 508 a year ago. Basic earnings per share was KRW 460 compared to KRW 508 a year ago.
KYUNG DONG PHARMACEUTICAL CO.,LTD. is a Korea-based company engaged in the manufacture and marketing of pharmaceutical products. The Companyâs products include liver therapies, gastrointestinal drugs, antimigraine drugs, antiviral, anti-obesity medications, antibacterial drugs, antidiabetic drugs, antifungal, allergy medications, antispasmodics, antihistamines, vitamins, as well as drugs for osteoporosis, cardiovascular, muscle relaxant, neuropathic and other diseases. It also provides various over-the-counter (OTC) drugs, such as anti-inflammatory medicines, antiviral drugs, antihistamine drugs, gastrointestinal drugs and others. In addition, the Company engages in the leasing of real estate, and distribution of snowboards and health functional food.
KYUNG DONG PHARMACEUTICAL CO., LTD. 